Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2021 · 10-Q
Revenue$31.86M$31.86M+24.8% vs Q2 2020 Net Income$2.68M$2.68Mno prior Q2 2020 on file EPS Diluted$0.51$0.51−30.1% vs Q2 2020 Gross Profit$21,285,000+36.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$10,542,000+64.1% Free Cash Flowderived$10,051,000+64.6% Margins · derivedGross margin66.8%+5.8 pt vs Q2 2020
Operating margin14.0%−4.4 pt vs Q2 2020
Net margin8.4%
ended Sep 30, 2020 · filed Nov 5, 2020 · 36 d after period end